{"rows":[{"id":1826,"title":"Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.","authors":"Averill LA, Abdallah CG","journal":"Expert opinion on investigational drugs","publication_date":"2022-02-01","publication_year":2022,"doi":"10.1080/13543784.2022.2035358","pubmed_id":"35188023","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/35188023/","substance_tags":"psilocybin","topic_tags":"PTSD,Neuroplasticity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:21","bibtex":null,"source_record_id":"PMID:35188023","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35188023","source_url":"https://pubmed.ncbi.nlm.nih.gov/35188023/","doi":"10.1080/13543784.2022.2035358","pmid":"35188023","publication_date":"2022-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1683,"title":"New investigational agents for the treatment of major depressive disorder.","authors":"Pochwat B, Krupa AJ, Siwek M, Szewczyk B","journal":"Expert opinion on investigational drugs","publication_date":"2022-10-01","publication_year":2022,"doi":"10.1080/13543784.2022.2113376","pubmed_id":"35975761","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/35975761/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Receptor Pharmacology,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:19","bibtex":null,"source_record_id":"PMID:35975761","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35975761/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35975761","source_url":"https://pubmed.ncbi.nlm.nih.gov/35975761/","doi":"10.1080/13543784.2022.2113376","pmid":"35975761","publication_date":"2022-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1442,"title":"What is the progress of experimental drug development for fibromyalgia?","authors":"Lawson K","journal":"Expert opinion on investigational drugs","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1080/13543784.2023.2230118","pubmed_id":"37357750","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/37357750/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:14","bibtex":null,"source_record_id":"PMID:37357750","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37357750","source_url":"https://pubmed.ncbi.nlm.nih.gov/37357750/","doi":"10.1080/13543784.2023.2230118","pmid":"37357750","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1434,"title":"Assessing potential of psilocybin for depressive disorders.","authors":"Kozak Z, Johnson MW, Aaronson ST","journal":"Expert opinion on investigational drugs","publication_date":"2023-01-01","publication_year":2023,"doi":"10.1080/13543784.2023.2273493","pubmed_id":"37869790","openalex_id":"https://openalex.org/W4387866078","source_url":"https://pubmed.ncbi.nlm.nih.gov/37869790/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:14","bibtex":null,"source_record_id":"PMID:37869790","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37869790/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37869790","source_url":"https://pubmed.ncbi.nlm.nih.gov/37869790/","doi":"10.1080/13543784.2023.2273493","pmid":"37869790","publication_date":"2023-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":4,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Expert opinion on investigational drugs","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}